A revised AAP clinical practice guideline on the diagnosis and management of bronchiolitis updates the 2006 guideline with stronger recommendations, addition of new therapies and significantly revised recommendations on the use of palivizumab.

Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis is published in the November issue of Pediatrics (


In 2012, a multi-disciplinary committee was formed to revise the 2006 guideline due to the publication of a significant amount of new literature on the disease in the intervening years. The committee reviewed literature published since completion of the 2006 guideline as well as the literature included in the earlier document. As a result, multiple changes were made.

The new document, from the AAP Subcommittee on Bronchiolitis, emphasizes that bronchiolitis is a clinical diagnosis that may be caused by a number of viruses. Up to 30% of patients may...

You do not currently have access to this content.